Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2013 - 2026)
Tandem Diabetes Care posted quarterly Total Non-Current Liabilities of $970.6 million for Q1 2026, up 33.0% year-on-year from $729.8 million in Q1 2025, and up 43.53% on a QoQ basis from $676.2 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Total Non-Current Liabilities data on file, last reported at $970.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 33.0% year-over-year to $970.6 million; the trailing twelve-month figure through Mar 2026 stood at $970.6 million (up 33.0% YoY), and the FY2025 full-year result was $676.2 million, up 0.6% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $970.6 million, up from $676.2 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $970.6 million in Q1 2026 and bottomed at $560.4 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $665.5 million (2024), against an average of $656.9 million.
- The widest annual swing landed in 2022, when Total Non-Current Liabilities jumped 35.84%; it then dropped 0.15% in 2023.
- A 5-year view of Total Non-Current Liabilities shows it stood at $588.9 million in 2022, then climbed by 3.1% to $607.2 million in 2023, then advanced by 10.7% to $672.2 million in 2024, then rose by 0.6% to $676.2 million in 2025, then surged by 43.53% to $970.6 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $970.6 million (Q1 2026), $676.2 million (Q4 2025), and $689.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 970.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 970.58 Mn |
| Dec 31, 2025 | 676.20 Mn |
| Sep 30, 2025 | 689.31 Mn |
| Jun 30, 2025 | 690.39 Mn |
| Mar 31, 2025 | 729.79 Mn |
| Dec 31, 2024 | 672.19 Mn |
| Sep 30, 2024 | 687.78 Mn |
| Jun 30, 2024 | 671.13 Mn |
| Mar 31, 2024 | 665.50 Mn |
| Dec 31, 2023 | 607.20 Mn |
| Sep 30, 2023 | 601.79 Mn |
| Jun 30, 2023 | 592.49 Mn |
| Mar 31, 2023 | 591.59 Mn |
| Dec 31, 2022 | 588.92 Mn |
| Sep 30, 2022 | 602.67 Mn |
| Jun 30, 2022 | 569.75 Mn |
| Mar 31, 2022 | 560.45 Mn |
| Dec 31, 2021 | 454.19 Mn |
| Sep 30, 2021 | 460.51 Mn |
| Jun 30, 2021 | 446.38 Mn |
| Mar 31, 2021 | 412.59 Mn |
| Dec 31, 2020 | 335.85 Mn |
| Sep 30, 2020 | 329.04 Mn |
| Jun 30, 2020 | 308.91 Mn |
| Mar 31, 2020 | 110.86 Mn |
| Dec 31, 2019 | 107.62 Mn |
| Sep 30, 2019 | 102.37 Mn |
| Jun 30, 2019 | 100.82 Mn |
| Mar 31, 2019 | 87.37 Mn |
| Dec 31, 2018 | 57.09 Mn |
| Sep 30, 2018 | 45.53 Mn |
| Jun 30, 2018 | 119.70 Mn |
| Mar 31, 2018 | 114.79 Mn |
| Dec 31, 2017 | 119.06 Mn |
| Sep 30, 2017 | 109.15 Mn |
| Jun 30, 2017 | 109.87 Mn |
| Mar 31, 2017 | 106.95 Mn |
| Dec 31, 2016 | 111.87 Mn |
| Sep 30, 2016 | 81.69 Mn |
| Jun 30, 2016 | 73.67 Mn |
| Mar 31, 2016 | 71.40 Mn |
| Dec 31, 2015 | 58.54 Mn |
| Sep 30, 2015 | 54.73 Mn |
| Jun 30, 2015 | 51.05 Mn |
| Mar 31, 2015 | 50.78 Mn |
| Dec 31, 2014 | 50.23 Mn |
| Sep 30, 2014 | 47.93 Mn |
| Jun 30, 2014 | 45.61 Mn |
| Mar 31, 2014 | 44.40 Mn |
| Dec 31, 2013 | 45.88 Mn |